about
GABA induces the differentiation of small into large cholangiocytes by activation of Ca(2+) /CaMK I-dependent adenylyl cyclase 8.Recent advances in the regulation of cholangiocyte proliferation and function during extrahepatic cholestasisAfter damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.Taurocholic acid prevents biliary damage induced by hepatic artery ligation in cholestatic rats.Polycystic liver diseases.Recent advances on the mechanisms regulating cholangiocyte proliferation and the significance of the neuroendocrine regulation of cholangiocyte pathophysiology.Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.Gonadotropin-releasing hormone stimulates biliary proliferation by paracrine/autocrine mechanismsAbnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease.Ischemia reperfusion of the hepatic artery induces the functional damage of large bile ducts by changes in the expression of angiogenic factors.Activation of alpha(1) -adrenergic receptors stimulate the growth of small mouse cholangiocytes via calcium-dependent activation of nuclear factor of activated T cells 2 and specificity protein 1.Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanismsNeuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.Morphological and functional heterogeneity of the mouse intrahepatic biliary epitheliumTaurocholate feeding to bile duct ligated rats prevents caffeic acid-induced bile duct damage by changes in cholangiocyte VEGF expression.Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expressionMelatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease.H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.Role of lactoferrin and its receptors on biliary epitheliumKnockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2-/- mice by diminishing senescence of cholangiocytesNeuroendocrine Changes in Cholangiocarcinoma GrowthModulation of STAT3 Signaling, Cell Redox Defenses and Cell Cycle Checkpoints by β-Caryophyllene in Cholangiocarcinoma Cells: Possible Mechanisms Accounting for Doxorubicin Chemosensitization and ChemopreventionViral Hepatitis and Iron Dysregulation: Molecular Pathways and the Role of Lactoferrin
P50
Q30542145-49320CE0-58A6-44F2-95E2-E75214EE24B4Q33718790-3B6B2CFA-EB95-46A9-B1AF-53DD52448473Q33745195-B24C82DA-AB05-4E37-BD98-BE01BF7CE190Q33783730-68F2CA89-1A6B-4CE7-B3AC-DE1B77CC31DBQ33936280-213AF2EA-3636-4833-80B6-4DC383E18088Q33949172-A7440CE5-29B1-493C-A999-AAD096D5F3E3Q34358007-574C9C5B-C57E-4FD8-921E-F636B5C26939Q34439817-D22505C2-25D8-4031-BD47-03AFBACF4EC4Q34636044-C755EA98-E3BB-4D6F-A9B7-F171E57EC499Q35236464-195E5D36-21FE-4FF6-A462-E1F75BDFAAB9Q35969183-5976EB7E-07B3-4622-B24B-C29B3FFC9F6FQ36345910-0704E3CA-0F14-4A2A-BF3A-4878FD043895Q36466409-4BC3EDD9-E845-4DE4-B6A8-D235D531711EQ36807790-A110C5C4-641E-4763-BB42-6E0BB4A2AC6AQ37093626-EF636730-D568-431F-8359-A0B5D4EAE502Q37142524-DCE91DB2-3C0B-4651-B36C-BA219A5E80A7Q37157705-8C79B1CA-DBB9-4A7D-B878-FEAD51DE7DBEQ37253350-F58B3CB2-2C32-40C5-9E3C-09CEA2383A55Q38682140-AF8D9E58-6A8A-4E34-92A8-27D740AAC0ABQ38737946-BDD5BF19-3B4E-4FA2-AA3D-10115DA0727FQ39787871-DD167DEF-057F-4D68-9013-A27F9797F7B1Q47850237-F40ED8E2-E2D7-461F-9016-A117DFF2853DQ47886786-6141BC91-950E-4E98-9FAA-2F2745D077D6Q48146413-61639AC5-9CF3-4B73-A6A8-43AFFD61E7B2Q57118006-C149C4E7-A26C-44A6-8E49-E5AAF7EDBB29Q89435538-93B81CCC-8727-46C6-B3A2-068F53D2EAB3Q89761775-BC59F5F5-4167-484D-BCA9-2891C22B56FCQ91602739-0F05943C-BB4F-4AB5-A721-5EC7D70EB2D1Q94448735-3E5BF750-4CB1-41B7-B51F-4DFBC2666F41
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Romina Mancinelli
@ast
Romina Mancinelli
@en
Romina Mancinelli
@es
Romina Mancinelli
@nl
type
label
Romina Mancinelli
@ast
Romina Mancinelli
@en
Romina Mancinelli
@es
Romina Mancinelli
@nl
prefLabel
Romina Mancinelli
@ast
Romina Mancinelli
@en
Romina Mancinelli
@es
Romina Mancinelli
@nl
P106
P1153
35230417000
P31
P496
0000-0003-2040-0581